Oxford Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,583
Closed -$341K – 644
2026
Q1
$341K Buy
+10,583
New +$392K 0.14% 230
2025
Q3
– Sell
-10,550
Closed -$285K – 757
2025
Q2
$285K Buy
+10,550
New +$306K 0.09% 332
2019
Q3
– Sell
-136,142
Closed -$3.88M – 1966
2019
Q2
$3.88M Sell
136,142
-50,720
-27% -$1.27M 0.08% 346
2019
Q1
$4.67M Sell
186,862
-30,706
-14% -$586K 0.1% 225
2018
Q4
$2.74M Buy
217,568
+17,446
+9% +$206K 0.07% 329
2018
Q3
$1.93M Buy
200,122
+177,221
+774% +$1.95M 0.04% 681
2018
Q2
$213K Sell
22,901
-21,968
-49% -$154K ﹤0.01% 1576
2018
Q1
$249K Buy
44,869
+1,279
+3% +$7.91K 0.01% 1447
2017
Q4
$286K Sell
43,590
-37,137
-46% -$276K 0.01% 1352
2017
Q3
$699K Buy
80,727
+38,780
+92% +$315K 0.01% 1093
2017
Q2
$349K Sell
41,947
-9,829
-19% -$80.2K 0.01% 1214
2017
Q1
$475K Sell
51,776
-46,975
-48% -$384K 0.01% 1067
2016
Q4
$764K Buy
+98,751
New +$739K 0.03% 525

Other funds holding VCYT

Oxford Asset Management's VCYT Position: Q2 2026 in Review

Oxford Asset Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 10,583 shares — an estimated $341K sold.

Oxford Asset Management first reported a position in VCYT in Q4 2016 and held it in 13 quarters. The position peaked at $4.67M in Q1 2019. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Oxford Asset Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Oxford Asset Management sold 10,583 Veracyte shares in Q2 2026, an estimated $341K.
  • Oxford Asset Management first reported a position in Veracyte in Q4 2016 and held it in 13 quarters.
  • Oxford Asset Management's Veracyte position peaked at $4.67M in Q1 2019.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.